pH值与幽门螺杆菌——胃酸分泌与幽门螺杆菌：对溃疡愈合及该病原体根除的影响 - Suppr

Suppr

超能文献

pH and Hp--gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism.

作者信息

Hunt R H

出版信息

Am J Gastroenterol. 1993 Apr;88(4):481-3.

PMID:8470623

Abstract

摘要

相似文献

pH and Hp--gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism.pH值与幽门螺杆菌——胃酸分泌与幽门螺杆菌：对溃疡愈合及该病原体根除的影响

Am J Gastroenterol. 1993 Apr;88(4):481-3.

[Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].[兰索拉唑/阿莫西林与奥美拉唑/阿莫西林对十二指肠溃疡患者根除幽门螺杆菌的比较效果]

Schweiz Med Wochenschr. 1997 Apr 26;127(17):722-7.

Short-term eradication therapy for Helicobacter pylori does not reduce the incidence of gastric metaplasia in duodenal ulcer patients.幽门螺杆菌短期根除治疗不能降低十二指肠溃疡患者胃化生的发生率。

Pol J Pathol. 1997;48(2):103-6.

Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.奥美拉唑、阿莫西林联合甲硝唑对幽门螺杆菌根除及十二指肠溃疡愈合的影响：与历史对照比较

Hepatogastroenterology. 1999 Jul-Aug;46(28):2358-62.

Duodenal ulcer healing drugs.

Lancet. 1994 Apr 9;343(8902):915.

Duodenal ulcer healing drugs.

Lancet. 1994 Apr 9;343(8902):915-6.

Acid secretion, response to omeprazole, and Helicobacter pylori status.

Am J Gastroenterol. 1997 Apr;92(4):555-6.

Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).双疗法（奥美拉唑和阿莫西林）治疗幽门螺杆菌相关性十二指肠溃疡和胃溃疡的多中心评估（两年观察期）

J Physiol Pharmacol. 1997 Sep;48 Suppl 4:93-105.

[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].[采用甲硝唑的新型一周三联疗法根除幽门螺杆菌：以克拉霉素或阿莫西林作为第二种抗生素]

Med Clin (Barc). 1998 Jan 17;110(1):1-5.

[The MACH2 Study: value of inhibiting gastric acid secretion in eradication of Helicobacter pylori with a one week triple therapy protocol].

Z Gastroenterol. 2000 Jan;38(1):131-2.

引用本文的文献

Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for Infection: A Systematic Review.含抗生素加质子泵抑制剂或沃克奥美拉唑的双重疗法治疗感染：一项系统评价

Microorganisms. 2025 Mar 21;13(4):715. doi: 10.3390/microorganisms13040715.

Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments.钾离子竞争型酸阻断剂：当前临床应用与未来发展。

Curr Gastroenterol Rep. 2024 Nov;26(11):273-293. doi: 10.1007/s11894-024-00939-3. Epub 2024 Aug 15.

Influence of Genotype on Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis.基因型对质子泵抑制剂-阿莫西林-克拉霉素根除治疗的影响：一项荟萃分析。

Front Pharmacol. 2021 Oct 15;12:759249. doi: 10.3389/fphar.2021.759249. eCollection 2021.

Effect of Antibiotic Susceptibility and and Genotype on the Outcome of Vonoprazan-Containing Eradication Therapy.抗生素敏感性和基因型对含沃克帕唑根除治疗结果的影响。

Antibiotics (Basel). 2020 Sep 26;9(10):645. doi: 10.3390/antibiotics9100645.

Potent Acid Suppression with PPIs and P-CABs: What's New?质子泵抑制剂和钾离子竞争性酸阻滞剂的强效抑酸作用：有哪些新进展？

Curr Treat Options Gastroenterol. 2018 Dec;16(4):570-590. doi: 10.1007/s11938-018-0206-y.

Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of .基于沃克帕唑的三联疗法根除失败后的二线三联疗法。（原文句子不完整，翻译可能不太能准确表达完整意思）

Biomed Rep. 2018 Aug;9(2):169-174. doi: 10.3892/br.2018.1111. Epub 2018 Jun 11.

A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.新型胃酸抑制剂沃诺拉赞与埃索美拉唑根除幽门螺杆菌的比较研究

Digestion. 2016;94(4):240-246. doi: 10.1159/000454762. Epub 2016 Dec 29.

Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?钾竞争性酸阻滞剂（P-CABs）：它们终于准备好在酸相关疾病中崭露头角了吗？

Clin Transl Gastroenterol. 2015 Oct 29;6(10):e119. doi: 10.1038/ctg.2015.39.

One-day front-loading with four doses of rabeprazole followed by a standard twice-daily regimen provides sufficient acid inhibition in extensive metabolizers of CYP2C19.一日四次服用雷贝拉唑进行一日预负荷给药，随后采用标准的每日两次给药方案，可为CYP2C19的广泛代谢者提供足够的胃酸抑制作用。

Eur J Clin Pharmacol. 2015 Dec;71(12):1467-75. doi: 10.1007/s00228-015-1941-9. Epub 2015 Oct 2.

High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection.高剂量双重疗法治疗幽门螺杆菌感染优于标准一线治疗或挽救治疗。

Clin Gastroenterol Hepatol. 2015 May;13(5):895-905.e5. doi: 10.1016/j.cgh.2014.10.036. Epub 2014 Nov 14.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验